首页> 外文期刊>Expert opinion on drug delivery >Recent advances in polymeric microspheres for parenteral drug deliverypart 2
【24h】

Recent advances in polymeric microspheres for parenteral drug deliverypart 2

机译:肠胃外给药用聚合物微球的最新进展第2部分

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Currently marketed microsphere products are manufactured with the use of organic solvents which have a negative impact on the environment and stability of biological molecules. With recent advances in fabrication technologies, solvent free methods have demonstrated potential for the preparation of microspheres. Areas covered: New technical advances recently achieved in solvent based microsphere manufacturing processes have allowed for major improvement in product quality and properties. Novel solvent free fabrication methods combined with newly functionalized biodegradable polymers have been explored for their application in the preparation of microspheres containing biological molecules. Expert opinion: Novel fabrication methods for microspheres have been recently reported but technical challenges and development risks remain high for scale up from bench to industrial commercialization. While the applications of microspheres for delivery of proteins, genes and vaccines have shown promise for clinical use, the approval of newly functionalized polymers as carriers may still face scrutiny on safety and biocompatibility, which can be key factors in securing the regulatory approval of the product.
机译:简介:目前市场上销售的微球产品是使用有机溶剂制造的,这些有机溶剂会对环境和生物分子的稳定性产生负面影响。随着制造技术的最新进展,无溶剂方法已显示出制备微球的潜力。涵盖的领域:溶剂型微球制造工艺中最近取得的新技术进步,使产品质量和性能有了重大改善。已经探索了与新功能化的可生物降解聚合物相结合的新型无溶剂制备方法,将其用于制备含有生物分子的微球。专家意见:最近已经报道了用于微球的新型制造方法,但是从台架规模扩大到工业化商业化,技术挑战和开发风险仍然很高。虽然微球用于递送蛋白质,基因和疫苗的应用已显示出可用于临床的前景,但新功能化聚合物作为载体的批准仍可能面临安全性和生物相容性的审查,这可能是确保产品监管批准的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号